|
Nov 30
|
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease
|
|
Nov 20
|
SNGX: Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperature…
|
|
Nov 17
|
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
|
|
Aug 11
|
BioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
|
|
Aug 10
|
HyBryte™ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment
|